Latest Breaking News On - Abnormal tau - Page 1 : comparemela.com

Marvel Biosciences Corp. , and its wholly owned subsidiary, Marvel Biotechnology Inc. , today reported promising interim results from its acute study on MB-204 conducted by Professor Emmanuel Planel.

Mark williamsEmmanuel planelMarvel biotechnology incRegulation services providerAlberta newsfile corpLaval universityMarvel biosciences corpVenture exchangeCompany or marvelMarvel biotechnologyProfessor emmanuel planelAbnormal tauChronic traumatic encephalopathyBiosciences corpChief executive officerChief science